Canopy Growth Corporation (WEED.TO)
CAD 4.07
(-7.08%)
CAD 4.07
(-7.08%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -312.82 Million CAD | -105.04% |
| 2022 | -2.87 Billion CAD | 862.14% |
| 2021 | -121.15 Million CAD | -233.93% |
| 2020 | -1.49 Billion CAD | 112.63% |
| 2019 | -1.31 Billion CAD | -180.81% |
| 2018 | -631.82 Million CAD | -422.91% |
| 2017 | -29.79 Million CAD | -1453.32% |
| 2016 | -692 Thousand CAD | 165.35% |
| 2015 | 938 Thousand CAD | 136.35% |
| 2014 | -6.96 Million CAD | -664.63% |
| 2013 | -925.98 Thousand CAD | -1333.24% |
| 2012 | -64.6 Thousand CAD | -147.01% |
| 2011 | -26.15 Thousand CAD | -8.68% |
| 2010 | -24.06 Thousand CAD | 10.59% |
| 2009 | -26.91 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -10.28 Million CAD | -42.61% |
| 2023 Q1 | -51.72 Million CAD | -122.86% |
| 2023 Q2 | -8.11 Million CAD | 84.32% |
| 2023 Q3 | -11.01 Million CAD | -35.76% |
| 2023 Q4 | -22.5 Million CAD | -104.31% |
| 2023 FY | - CAD | -105.04% |
| 2022 Q2 | -66.61 Million CAD | -104.06% |
| 2022 Q1 | 1.63 Billion CAD | 3561.9% |
| 2022 Q3 | -88.64 Million CAD | -33.06% |
| 2022 Q4 | 226.32 Million CAD | 355.32% |
| 2022 FY | - CAD | 862.14% |
| 2021 Q2 | -210.33 Million CAD | -251.67% |
| 2021 FY | - CAD | -233.93% |
| 2021 Q1 | 138.67 Million CAD | 270.02% |
| 2021 Q3 | -21.51 Million CAD | 89.77% |
| 2021 Q4 | -47.36 Million CAD | -120.12% |
| 2020 Q3 | -479.18 Million CAD | -23286.48% |
| 2020 Q1 | -173.17 Million CAD | 91.74% |
| 2020 Q2 | -2.04 Million CAD | 98.82% |
| 2020 FY | - CAD | 112.63% |
| 2020 Q4 | -81.56 Million CAD | 82.98% |
| 2019 Q4 | -2.09 Billion CAD | -1491.7% |
| 2019 Q1 | -44.95 Million CAD | 63.61% |
| 2019 Q2 | -73.72 Million CAD | -63.99% |
| 2019 Q3 | -131.66 Million CAD | -78.6% |
| 2019 FY | - CAD | -180.81% |
| 2018 Q2 | -198.83 Million CAD | -559.27% |
| 2018 Q4 | -123.54 Million CAD | 11.95% |
| 2018 Q3 | -140.31 Million CAD | 29.43% |
| 2018 Q1 | -30.16 Million CAD | 25.31% |
| 2018 FY | - CAD | -422.91% |
| 2017 Q2 | 5.89 Million CAD | 136.96% |
| 2017 Q3 | -63.93 Million CAD | -1184.08% |
| 2017 FY | - CAD | -1453.32% |
| 2017 Q1 | 2.48 Million CAD | 130.77% |
| 2017 Q4 | -40.38 Million CAD | 36.85% |
| 2016 FY | - CAD | 165.35% |
| 2016 Q4 | -8.08 Million CAD | -185.49% |
| 2016 Q3 | 9.46 Million CAD | 12.63% |
| 2016 Q2 | 8.4 Million CAD | 385.36% |
| 2016 Q1 | -2.94 Million CAD | 29.9% |
| 2015 FY | - CAD | 136.35% |
| 2015 Q3 | -1.17 Million CAD | -117.55% |
| 2015 Q4 | -4.2 Million CAD | -257.45% |
| 2015 Q2 | 6.69 Million CAD | 431.02% |
| 2015 Q1 | 1.26 Million CAD | 889.93% |
| 2014 Q4 | -159.6 Thousand CAD | 93.57% |
| 2014 FY | - CAD | -664.63% |
| 2014 Q1 | -1.12 Million CAD | 5.6% |
| 2014 Q3 | -2.48 Million CAD | -8.66% |
| 2014 Q2 | -2.28 Million CAD | -103.37% |
| 2013 Q4 | -1.18 Million CAD | -4118.78% |
| 2013 FY | - CAD | -1333.24% |
| 2013 Q1 | -37.75 Thousand CAD | -667.75% |
| 2013 Q2 | -7269.00 CAD | 80.75% |
| 2013 Q3 | -28.19 Thousand CAD | -287.92% |
| 2012 Q3 | -11.92 Thousand CAD | 45.98% |
| 2012 FY | - CAD | -147.01% |
| 2012 Q2 | -22.07 Thousand CAD | -508.66% |
| 2012 Q4 | -4918.00 CAD | 58.76% |
| 2012 Q1 | -3627.00 CAD | 58.33% |
| 2011 Q3 | -8984.00 CAD | -273.09% |
| 2011 Q1 | -377.00 CAD | 95.01% |
| 2011 Q2 | -2408.00 CAD | -538.73% |
| 2011 Q4 | -8705.00 CAD | 3.11% |
| 2011 FY | - CAD | -8.68% |
| 2010 Q1 | -138.00 CAD | 98.43% |
| 2010 Q4 | -7548.00 CAD | 43.0% |
| 2010 FY | - CAD | 10.59% |
| 2010 Q3 | -13.24 Thousand CAD | -283.97% |
| 2010 Q2 | -3449.00 CAD | -2399.28% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q3 | -18 Thousand CAD | 0.0% |
| 2009 Q4 | -8777.00 CAD | 51.25% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aurora Cannabis Inc. | 20.47 Million CAD | 1627.923% |
| Avicanna Inc. | -7.35 Million CAD | -4152.989% |
| Avant Brands Inc. | 4.83 Million CAD | 6568.714% |
| Cardiol Therapeutics Inc. | -27.87 Million CAD | -1022.051% |
| Crescita Therapeutics Inc. | 45 Thousand CAD | 695271.111% |
| Knight Therapeutics Inc. | 40.89 Million CAD | 864.914% |
| MediPharm Labs Corp. | -10.47 Million CAD | -2885.56% |
| OrganiGram Holdings Inc. | -207.61 Million CAD | -50.673% |
| Willow Biosciences Inc. | -11.06 Million CAD | -2728.198% |
| Auxly Cannabis Group Inc. | -10.82 Million CAD | -2789.857% |